Swiss stocks - Factors to watch on August 31
31/08/2020 05:55
ZURICH/BERLIN, Aug 31 (Reuters) - Here are some of the main
factors that may affect Swiss stocks on Monday:
CORONAVIRUS
U.S. cases of the novel coronavirus surpassed 6 million as
many states in the Midwest reported increasing infections.
urn:newsml:reuters.com:*:nL1N2FW08I
Sinovac Biotech's SVA.O coronavirus vaccine candidate
CoronaVac was approved for emergency use as part of a programme
in China to vaccinate high-risk groups such as medical staff, a
person familiar with the matter said. urn:newsml:reuters.com:*:nL4N2FV050
CREDIT SUISSE CSGN.S
Credit Suisse plans to double its headcount in China over
five years, Bloomberg reported. urn:newsml:reuters.com:*:nL4N2FW0JQ
LUFTHANSA LHAG.DE
The German airline's Swiss unit estimates that it will take
until 2024 for it to return to the number of planes operating
that it had before the coronavirus pandemic, Swiss board of
directors member Andre Blattmann told newspaper Blick https://www.blick.ch/news/wirtschaft/andre-blattmann-ueber-swiss-armee-und-corona-wir-erleben-gerade-eine-zaesur-id16067232.html.
ARYZTA ARYN.S
U.S. hedge fund Elliott Management is exploring a bid for
the baking company, Bloomberg reported. urn:newsml:reuters.com:*:nL4N2FU4KE
Additionally, a shareholder group represented by Veraison
said https://bit.ly/31FsXIB it is pleased that all proxy
advisors support "the need for a comprehensive renewal" of
Arzyta's board and added at least two of the three shareholder
group's candidates are supported by all proxy advisors.
COMPANY STATEMENTS
* Novartis NOVN.S said a new analysis shows high
consistency in lowering low-density lipoprotein cholesterol
(LDL-C) with its investigational treatment inclisiran.
urn:newsml:reuters.com:*:nPn4W4H2Ha Additionally, it announced phase II data for
LNP023, an investigational oral treatment for paroxysmal
nocturnal hemoglobinuria (PNH), and said it substantially
improved hematological response as an add-on therapy to
eculizumab. urn:newsml:reuters.com:*:nGNE92zK1z
* Helvetica Property Investors HSCF.S reported https://bit.ly/31HTW6z
an H1 net income of 2 million Swiss francs.
* Rapid Nutrition RAPI.S said it generated revenues of
$3.4 million in H1 and added it continues to realise a strong
market demand for health supplements despite the pandemic.
urn:newsml:reuters.com:*:nEQ5BZfXGa
ECONOMY
* Swiss July retail sales due at 0630 GMT
* SNB sight deposits due at 0800 GMT
(Reporting by Zurich newsroom and Berlin Speed Desk)
((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German .SDE
All SMI constituent stocks 0#.SSMI
DJ STOXX index .STOXX
Top 10 STOXX sectors .PGL.STOXXS
Top 10 EUROSTOXX sectors .PGL.STOXXES
Swiss mid-cap index .SSMI
Swiss all-share index .SSHI
Swiss market digest .AD.S
Sector overview CH/SECTOR1
All Swiss news CH
Swiss research news CH-RCH
All equity news E
SPEED GUIDES: EQUITY EQUITY/NEWS1 EUR/EQUITY SWITZERLAND REUTERS ))